Sponsors

FEATURE ARTICLES

H. pylori-specific antigens in stool samples: qualitative detection

Detection of the Helicobacter pylori antigen in faeces is the most common method used to diagnose infection. Here, Sarah Coleman and Steve Davies compared their current methodology with three commercially available palette tests.

Timing of cardiac surgery in patients suffering with COVID-19 disease

Cardiac surgery in patients diagnosed with COVID-19 disease carries significant mortality and morbidity, but the appropriate period to wait before surgical intervention after recovery is not known. Ana Lopez-Marco and colleagues explore the issues.

Method comparisons with quantitative data I: a look at basic summaries

Stephen MacDonald moves on from consideration of the various factors that need investigation before implementation of an assay, to focus here on data collection, basic graphing techniques, and some routine statistical methods.

IVD Regulation changes in the United Kingdom in the post-Brexit era.

Doris-Ann Williams discusses how IVDs will be regulated in a newly independent UK after being regulated under the IVD Directive for the past 20 years, and the effects this may have on industry and clinical laboratories in the UK.

Potential impacts of the EU IVD-Regulation on clinical flow cytometry.

Maurizio Suppo provides an overview of the new EU IVD-Regulation and elaborates on how EU authorities will regulate the vast majority of the laboratory-developed tests currently performed across Europe on a daily basis.

Non-gynaecological cytopathology: the importance of preparation

Beverley Crossley provides an overview of the techniques applicable to the various sample types encountered in routine practice.

Overcoming challenges in ketone testing: from diabetes to sepsis

The detection and monitoring of patients suffering from ketoacidosis continues to increase the laboratory medicine workload. Here, Randox Laboratories examines the issues and illustrates the scope of the problem.

Fighting AMR in the era of SARS-CoV-2 and COVID-19 disease

The threat posed by antimicrobial resistance was high on the agenda at the FIS/HIS International online conference, where Evelina Tacconelli called for action. Louise Frampton reports on proceedings.

Commerce and COVID-19: a need for reconfiguration and transformation

The in vitro diagnostics industry has been at the forefront of the fight against SARS-CoV-2. Here, Mark Reed provides a commercial perspective and overview of the unprecedented times experienced over the past 12 months.

Method comparison studies: an introduction to acceptability criteria

In this third article in his series on method comparisons, Stephen MacDonald moves on to focus on what differences are expected and acceptable, and what other factors need further investigation before implementation of an assay.

Innovative haemostasis systems for routine and special testing

The CN-Series of analysers from Sysmex has now undergone multi-centre validation and verification work in the UK ahead of global introduction in 2021. Here, the company introduces the equipment and its various hardware and software features.

Hepatology: researching cirrhosis, HBV and intestinal microflora

A report on the impact of COVID-19 on patients with decompensated cirrhosis, along with an overview of HBV and the role of intestinal microflora in alcohol-related liver disease.

Barrett’s metaplasia: subtyping, stem cells and receptors

Gastroesophageal reflux disease (GERD) is a common condition which, if left untreated, may result in intestinal metaplasia, a premalignant condition that occurs in the upper gastrointestinal tract.

Plasma viscosity: accuracy, precision and suitability – who wants it?

The diagnostic and prognostic value of plasma viscosity has been highlighted in patients suspected or confirmed as having COVID-19, but its use in other areas of UK medical practice has gained clinical acceptance over the past seven decades.

Hepatitis B virus: a small selection of research in the literature

Hepatitis B, a potentially life-threatening liver infection caused by the hepatitis B virus (HBV), is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer.

Releasing pressure on pathology services: RFID technology has the key

With the NHS continuing to struggle as it responds to the current SARS-CoV-2 pandemic and the effects that COVID-19 disease is having on a heavy workload, Gillian Ewers examines the advantages that RFID and a transport and tracking system offer.

Biomedical laboratory Science: an international perspective

The International Federation of Biomedical Laboratory Science has a global responsibility to support, advance and promote good scientific laboratory practice and education. Here, new IFBLS President Alan Wainwright provides an overview.

Reducing the COVID-19 burden: diagnostics and the patient pathway

Tony Cambridge looks at a changing healthcare landscape as the service continues to respond to the ongoing coronavirus pandemic, and considers the important role of point-of-care tests and combination testing.

Diagnostic testing in cases of SARS-CoV-2 adverse outcomes

Severe cases of COVID-19 disease exhibit a range of immunological, kidney, liver and heart complications that require laboratory investigation. Randox Laboratories provides an overview and looks at quality control and assessment of testing.

Pathology partnership strengthened during SARS-CoV-2 pandemic

Award-winning NHS partnership SWLP has adopted equipment from Beckman Coulter’s AutoMate 2500 family of sample processing systems, which has streamlined pre- and post-analytical processes to help gain optimal performance and use of resources.

Latest Issues

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-11 March, 2025